Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05458674
What this trial is testing

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Who this might be right for
Breast CancerPretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Criterium, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT04997902
What this trial is testing

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Who this might be right for
HNSCC
Kura Oncology, Inc. 45
Very early researchLooking for participantsNCT07649928
What this trial is testing

Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 24
Testing effectiveness (Phase 2)Study completedNCT04401800
What this trial is testing

Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
BeiGene 64
Early research (Phase 1)UnknownNCT05010694
What this trial is testing

GH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early Results

Who this might be right for
Advanced Solid Tumors Harboring With G12C Mutation
Suzhou Genhouse Bio Co., Ltd. 18
Testing effectiveness (Phase 2)Ended earlyNCT03632941
What this trial is testing

Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Who this might be right for
Breast CancerHER2+ Breast Cancer
Herbert Lyerly 8
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07504263
What this trial is testing

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

Who this might be right for
Advanced MalignanciesOncologyColorectal Cancer+2 more
Recurv Pharma Inc 66
Early research (Phase 1)Not Yet RecruitingNCT07566247
What this trial is testing

A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumors
Akeso 96
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Early research (Phase 1)UnknownNCT05829616
What this trial is testing

A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 50
Early research (Phase 1)Study completedNCT06253195
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHormone-receptor-positive Breast Cancer+4 more
BeOne Medicines 33
Testing effectiveness (Phase 2)Looking for participantsNCT07193511
What this trial is testing

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+1 more
Avenzo Therapeutics, Inc. 355
Early research (Phase 1)Study completedNCT03261011
What this trial is testing

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Akesobio Australia Pty Ltd 119
Early research (Phase 1)Looking for participantsNCT05667194
What this trial is testing

Phase 1 Trial of KH617

Who this might be right for
Advanced Solid Tumors
Sichuan Honghe Biotechnology Co., Ltd. 45
Not applicableNot Yet RecruitingNCT07245251
What this trial is testing

To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004

Who this might be right for
Acute Lymphobkastic Leukemia
Starna Therapeutics 11
Testing effectiveness (Phase 2)Study completedNCT05002270
What this trial is testing

JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

Who this might be right for
Advanced Solid TumorNSCLCCRC
Jacobio Pharmaceuticals Co., Ltd. 29
Early research (Phase 1)Ended earlyNCT05351697
What this trial is testing

Clinical Study of BR105 Injection

Who this might be right for
Advanced Malignancies
BioRay Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Looking for participantsNCT06686394
What this trial is testing

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Who this might be right for
Breast NeoplasmsBreast Cancer
Merck Sharp & Dohme LLC 81
Large-scale testing (Phase 3)UnknownNCT05429697
What this trial is testing

Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
SMT bio Co., Ltd. 128
Next Page